Investing Profile

Lucio Iannone

InvestorVC
Head of Venture Investments at Leaps by Bayer
leaps.bayer.com/teamCambridge, Massachusetts
Photo of Lucio Iannone, Leaps by Bayer

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Imperial College London Network
168 CONNECTIONS
Imperial College London Network
168 CONNECTIONS
cb
$100K - $5.0M
$1.5M
6
CompanyStageDateRound SizeTotal Raised
EGenesis
Series DSep 2024$190M
Series CMar 2021$130M
Series BNov 2019$100M
$450M
Co-investors: Peter Hebert (Lux Capital), Steven Gillis (ARCH Venture Partners), Boris Nikolic (The Data Guild), Isaac Ciechanover
Paratus Sciences
Series AFeb 2023$100M
$100M
Mozart Therapeutics
Series AOct 2021$55M
$80M
Co-investors: Jasmina Marjanovic (Takeda Ventures, Inc.), Henrijette Richter (Sofinnova Partners), Peter Dudek (M Ventures (Merck)), Steven Gillis (ARCH Venture Partners)
Immunitas Therapeutics
Series BAug 2021$58M
$97M
Co-investors: Laura Brass (MPM BioImpact), Geeta Vemuri (Agent Capital), Christoph Westphal (Self-employed), Brian Halak (Medical Excellence Capital, LLC), Daniel Coley (Cofounders Capital)
Board Member Axxam S.p.APresent
Board Member Pyxis OncologyPresent
Board Member eGenesisPresent
Board Member Immunitas TherapeuticsPresent
Board Observer Metagenomi TherapeuticsPresent
Board Observer Azitra IncPresent
Board Member Vesigen Therapeutics, Inc.Present
Board Observer Kojin TherapeuticsPresent
Board Member Deka Biosciences, IncPresent
Board Member Mozart Therapeutics, Inc.Present
Board Member Mozart Therapeutics, IncPresent
Board Observer Edifice Health, Inc.Present
Head of Venture Investments Leaps by BayerPresent
Vice President of Venture Investments Leaps by BayerPresent
Board Observer GRO BiosciencesPresent
Board Member CellinoPresent
Board Observer CellinoPresent
Board Member Affini-T TherapeuticsPresent
Board Member Paratus SciencesPresent
Board Observer NextPoint Therapeutics, Inc.Present
Board Observer Boundless BioPresent
Board Member Soufflé TherapeuticsPresent
Board Observer Capstan TherapeuticsPresent
Senior Investment Advisor Amana Global PartnersPresent
Board Observer COUR PharmaPresent
Imperial College London Doctor of Philosophy (Ph.D.) Doctor of Philosophy (Ph.D.), Medicine
Imperial College London Doctor of Philosophy (Ph.D.) Medicine
Università degli Studi di Napoli 'Federico II'​ Bachelor's degree Biotechnology
Università degli Studi di Napoli Federico II Bachelor's degree Biotechnology
Università degli Studi di Napoli Federico II Bachelor's degree Bachelor's degree, Biotechnology
Università degli Studi di Napoli 'Federico II' Bachelor's degree Biotechnology
Cambridge University Department of Chemical Engineering and Biotechnology Master's degree Medical Biotechnology
Sign in with Google →
Sign in with Google →